For Immediate Release
January 14, 2023
Cranford, NJ – A Biotech Showcase panel at 8:00 am PT tomorrow will address the evolution of life-threatening pathogens like H5N1 Bird Flu. With the just-announced first U.S. case of H5N1 in a child in San Francisco, the need for novel responses to disease threats in a fast-changing world has become critical.
The panel, moderated by Dr. Steve Brozak, will address the compelling issues posed by these new deadly pathogens and will be followed by a Q&A.
The distinguished participating in the event are:
- Dr. Jeff Stein, President & CEO of Cidara Therapeutics
- Emma Wheatley, Executive Director of CEPI (Coalition for Epidemic Preparedness Innovations)
- Dr. Phillip Chan, CEO of CytoSorbents Corporation
- Dr. Niels Riedemann, CEO & Founder of InflaRx N.V.
About WBB Securities.
WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.
About Biotech Showcase.
Biotech Showcase is the investor and partnering conference for private, small- and mid-cap biotech companies. The event is organized by the EBD Group, which organizes a family of international partnering events to create a dynamic marketplace where thousands of industry professionals meet one-to-one to discuss the in- and out-licensing of assets, strategic collaborations, and financial investment. Each year EBD events generate more than 50,000 one-to-one meetings.
